Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Option Award |
2025-03-03 8:11 pm |
N/A 2035-02-27 |
Prime Medicine Inc. | PRME | Reine Allan Chief Financial Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2024-12-05 Option Award |
2024-12-09 6:22 pm |
N/A 2034-01-17 |
Prime Medicine Inc. | PRME | Reine Allan Chief Financial Officer |
75,000 | $0 | 775,000 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 4:11 pm |
N/A 2034-01-17 |
Prime Medicine Inc. | PRME | Reine Allan Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 4:19 pm |
N/A 2034-01-17 |
Prime Medicine Inc. | PRME | Reine Allan Chief Financial Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:02 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:26 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:14 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
26,892 | $0 | 311,296 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:14 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
26,892 | $3.72 | 311,296 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:26 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
Ownership |
2020-10-22 8:49 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
0 | $0 | 403,187 (Direct) |
View |